Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Twist Bioscience Corporation (TWST) had Return on Equity of -8.12% for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$75.30M |
|
$-45.49M |
|
$44.42M |
|
$30.88M |
|
$124.19M |
|
$-48.89M |
|
$3.74M |
|
$-45.15M |
|
$-45.15M |
|
$-45.49M |
|
$-45.49M |
|
$-45.49M |
|
$-45.49M |
|
$-48.89M |
|
$-40.59M |
|
57.78M |
|
57.78M |
|
$-0.79 |
|
$-0.79 |
|
| Balance Sheet Financials | |
$371.87M |
|
$121.34M |
|
$330.98M |
|
$702.85M |
|
$67.49M |
|
-- |
|
$75.22M |
|
$142.72M |
|
$560.13M |
|
$422.42M |
|
$560.13M |
|
58.16M |
|
| Cash Flow Statement Financials | |
$-42.40M |
|
$-1.07M |
|
$0.35M |
|
$289.28M |
|
$246.22M |
|
$-43.06M |
|
$24.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.51 |
|
-- |
|
-- |
|
-- |
|
-- |
|
41.01% |
|
-64.92% |
|
-64.92% |
|
-- |
|
-59.95% |
|
-60.41% |
|
$-44.51M |
|
-- |
|
-- |
|
-- |
|
0.11 |
|
1.46 |
|
2.09 |
|
43.02 |
|
|
Return on Equity |
-8.12% |
-10.77% |
|
-6.47% |
|
-8.12% |
|
$9.63 |
|
$-0.77 |
|
$-0.73 |
|